自体外周血造血干细胞移植治疗非霍奇金淋巴瘤56例临床分析
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Autologous peripheral blood hematopoietic stem cell transplantation in 56 patients with non-hodgkin’s lymphoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨自体外周血造血干细胞移植(autologous peripheral blood stem cell transplantation,APBSCT)治疗非霍奇金淋巴瘤(non-Hodgkin’s lymphoma,NHL)的临床疗效。方法:回顾性分析2009年2月至2013年10月在我院行APBSCT的NHL患者56例,其中男37例,女19例,中位年龄44岁(16~69)岁,缓解病例46例,部分缓解7例,复发难治3例。结果:56例移植患者中55例获造血重建,1例未造血重建。中性粒细胞绝对值>0.5×109个/L的中位时间9.5 d (7~18 d)、血小板计数>20×109个/L的中位时间11.5 d(6~24 d)。24例患者于粒细胞缺乏期时出现发热,5例出现轻中度腹泻,1例出现轻度肝功能损害,1例出现带状疱疹。所有患者随访截止于2014年4月1日,中位随访时间20.25月(3.0~60.5月)。45例存活(其中5例带病生存),10例复发,11例死亡(其中5例死于复发)。复发率为17.9%,总生存率(overall survival,OS)、无病生存率(disease free survival,DFS)分别为80.4%、71.4%。结论:APBSCT是治疗NHL的有效手段,造血重建快,并发症少。

    Abstract:

    Objective:To study the clinical efficacy of autologous peripheral blood hematopoietic stem cell transplantation(APBSCT) in the treatment of non-Hodgkin’s lymphoma(NHL). Methods:A total of 56 patients who underwent APBSCT from February 2009 to October 2013 in the hospital were enrolled in the study. There were 37 males and 19 females with a median age of 44 years(16-69 years);46 cases were in remission,7 cases in partial remission and 3 cases in relapsed or refractory. Results:Among 56 patients treated by APBSCT,55 patients obtained hematopoi-etic reconstitution. The median time for neutrophils recovery(>0.5×109/L) was 9.5(7-18) d and platelet recovery(>20×109/L) was 11.5(6-24) d. Twenty-four patients experienced fever during granulocyte lack phase,5 patients experienced mild-to-moderate diarrhea,one patient had mild liver function damage and one patient had herpes zoster. All patients were followed up till the 1st April,2014,and the median follow-up time was 20.25(3-60.5) months. Forty-five cases survived(5 cases alive with disease);10 cases relapsed;11 cases died(5 cases died of recurrence). The recurrence rate was 17.9%. Overall survival and disease-free survival were 80.4% and 71.4% respectively. Conclusion:With the advantages of quicker hematopoietic reconstruction and fewer non-Hodgkin’s lymphoma,APBSCT is effective in the treatment of NHL.

    参考文献
    相似文献
    引证文献
引用本文

张端众,肖 青,张红宾,唐晓琼,王建渝,王 欣,杨泽松,陈建斌,刘 林,王 利.自体外周血造血干细胞移植治疗非霍奇金淋巴瘤56例临床分析[J].重庆医科大学学报,2015,(1):154-157

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2015-11-09
  • 出版日期:
文章二维码